Leaky Gut Syndrome
Leaky Gut Syndrome Model Using Intestinal Organoids
An intestinal organoid-based in vitro model of leaky gut syndrome induced by epithelial barrier damage, characterized by tight junction disruption, increased permeability, and barrier dysfunction.
This human-relevant model enables quantitative evaluation of epithelial structure recovery and barrier function improvement in response to candidate compounds.
Challenges
Intestinal barrier dysfunction, marked by tight junction disruption and increased permeability, plays a central role in leaky gut syndrome and related inflammatory conditions. However, existing in vitro and animal models fail to accurately capture the human epithelial barrier architecture and dynamic recovery processes, limiting their translational value for compound screening and mechanism studies.
Discuss Your Intestinal Barrier Recovery Research
Our scientists will help design a human-relevant disease modeling study.
Intestinal Organoids Model of Leaky Gut Syndrome
This case study introduces a human intestinal organoid–based leaky gut model in which epithelial barrier dysfunction is experimentally induced and followed by compound-driven recovery. The model enables quantitative, reproducible assessment of epithelial structure restoration and functional barrier improvement in a human-relevant system.
Related Solutions
Leaky Gut Syndrome Modeling Workflow
Step 1: Organoid generation & barrier damage induction
Intestinal organoids are generated either from patient-derived intestinal stem cells or iPSCs differentiated toward an intestinal lineage, then cultured within an ECM-rich 3D environment that supports tissue maturation and long-term expansion. Controlled induction of epithelial barrier dysfunction subsequently enables modeling of tight junction disruption and increased intestinal permeability.
Step 2: Compound treatment & barrier recovery
Damaged organoids are treated with candidate compounds to promote epithelial structure recovery and improvement of intestinal barrier function.
Step 3: Quantitative recovery assessment & compound ranking
Barrier restoration is quantitatively evaluated through permeability measurements and tight junction marker analysis, enabling comparative assessment and ranking of compounds based on barrier recovery efficacy.
Discuss Your Intestinal Barrier Recovery Research
Our scientists will help design a human-relevant disease modeling study.
Impact
- Direct quantification Enables direct, quantitative evaluation of intestinal barrier recovery in a human-relevant system.
- Improved translation Improves translational confidence compared to conventional 2D or animal models.
- Non-animal alignment Supports non-animal, OECD-aligned testing strategies.
- Faster decision-making Accelerates compound prioritization based on barrier repair efficacy.
Ready to evaluate intestinal fibrosis in a human-based system?
Human-relevant disease modeling services by Lambda Biologics
